Back to Search
Start Over
Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections.
- Source :
- Open Forum Infectious Diseases; Sep2023, Vol. 10 Issue 9, p1-6, 6p
- Publication Year :
- 2023
- Subjects :
- CLOSTRIDIOIDES difficile
DURABILITY
INFECTION
BILE acids
Subjects
Details
- Language :
- English
- ISSN :
- 23288957
- Volume :
- 10
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Open Forum Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 172896087
- Full Text :
- https://doi.org/10.1093/ofid/ofad456